Saluda Medical Results of U.S. Evoke Pivotal Study through 12 Months Published in The Lancet Neurology

 

Saluda Medical Results of U.S. Evoke Pivotal Study through 12 Months Published in The Lancet Neurology

Demonstrates Evoke® ECAP-Controlled Closed-Loop SCS Provides Statistically Superior Pain Relief Compared to Open-Loop SCS ARTARMON, Australia, Dec. 20, 2019 /PRNewswire/ — Saluda Medical Pty Limited …

More Saluda Medical Results of U.S. Evoke Pivotal Study through 12 Months Published in The Lancet Neurology Videos

Leave a Reply